Skip to main content
GutCited

Description

Supplementary evidence table from the probiotics review (figure 20) documents additional trial characteristics, safety outcomes, and strain-specific effects in pediatric intensive care settings.

Figure 20

Source Paper

Probiotics in critically ill children.

F1000Research (2016)

PMID: 27081478

DOI: 10.12688/f1000research.7630.1

Cite This Figure

![Figure 20: Supplementary evidence table from the probiotics review (figure 20) documents additional trial characteristics, safety outcomes, and strain-specific effects in pediatric intensive care settings.]()

> Source: Sunit C Singhi et al. "Probiotics in critically ill children.." *F1000Research*, 2016. PMID: [27081478](https://pubmed.ncbi.nlm.nih.gov/27081478/)
<figure>
  <img src="" alt="Supplementary evidence table from the probiotics review (figure 20) documents additional trial characteristics, safety outcomes, and strain-specific effects in pediatric intensive care settings." />
  <figcaption>Figure 20. Supplementary evidence table from the probiotics review (figure 20) documents additional trial characteristics, safety outcomes, and strain-specific effects in pediatric intensive care settings.<br>  Source: Sunit C Singhi et al. "Probiotics in critically ill children.." <em>F1000Research</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27081478/">27081478</a></figcaption>
</figure>